Getting testosterone therapy right feels less like flipping a switch and more like tuning an instrument. Two people can start with the same vial, the same dose, and end up with very different results. The variation comes from metabolism, sex hormone binding globulin, body fat, absorption, and daily habits that change serum levels. The good news is that you can make hormone replacement therapy precise if you focus on three levers you can actually control: dose, delivery, and labs.
I have managed thousands of patient months of testosterone treatment across men seeking low T treatment, perimenopausal and postmenopausal women needing very low dose support, and transgender men in gender affirming hormone therapy. Patterns repeat, and the pitfalls are predictable. This guide distills what consistently works, where people get tripped up, and how I adjust plans when the numbers do not match the symptoms.
Why optimize at all
The aim of testosterone therapy is not a big number on a lab slip. The aim is function. Better energy and mood stability. Restorative sleep. Lean mass retention or gain. Lower visceral fat. A libido that fits your life. For many, the bonus is improved glycemic control and less brain fog. For some, it is about mood and resilience under stress. The rub is that benefits plateau. Push past physiologic levels and side effects climb: acne, oily skin, irritability, rising hematocrit, edema, snoring creeping into sleep apnea territory, and a disappointed partner who does not recognize the person across the table.
Optimal lives inside a range that fits the patient’s physiology and goals. I rely on symptoms first, labs second, and I never interpret labs in a vacuum.
The dose is a dial, not a value
A frequent starting point for testosterone replacement therapy is a standardized dose. That makes sense on day one and loses its utility by week four. Dosing belongs on a dial that moves in small increments, guided by how the person feels and how the labs look. A few principles help.
Small adjustments beat big swings. If a man starts with testosterone cypionate at 100 mg per week and reports good energy but afternoon irritability and mild acne, I do not jump to 200 mg per week. I either split the dose to twice weekly at the same total or increase to 110 to 120 mg and reassess. Injections create peaks and troughs. Splitting flattens the curve.
Serum targets are a means to an end. For most adult men on TRT, I try to live inside the middle to upper third of the lab’s total testosterone reference range without exceeding it. That often sits between 500 and 900 ng/dL, though reference intervals vary by lab and age. Free testosterone matters when SHBG is high or low. A man with high SHBG may feel low despite total testosterone at 700 ng/dL because the free fraction is restricted. In those cases, I titrate to a healthy free testosterone within the lab’s range rather than chasing total T.
Dose speaks through side effects. Acne and oily skin tell me dihydrotestosterone has risen quickly. A sharp jump in hematocrit often follows aggressive dosing or infrequent large injections. New or louder snoring means I check sleep and consider a smaller, more frequent schedule. Mild peripheral edema early in therapy is common and tends to improve with stable dosing.
Women require a different scale. In women, testosterone is sometimes used as part of bioidentical hormone replacement therapy for hypoactive sexual desire disorder or for stubborn fatigue and brain fog once estrogen and thyroid are addressed. Doses are one to two orders of magnitude lower than in men, most often compounded creams or sublingual drops with careful monitoring. Overshooting even modestly produces hair growth, acne, and voice changes. I move slowly, check levels with a reliable assay, and judge success by function and comfort.
In transgender men undergoing hormone therapy, starting doses are physiologic male ranges but the ramp up matters. A typical path begins with testosterone cypionate at 50 to 60 mg weekly or 25 to 30 mg twice weekly, then HRT specialists New Providence NJ titrated to achieve consistent male range levels and desired clinical changes over months. Acne and vaginal atrophy are common early issues and respond to targeted care without derailing the plan.
Delivery changes everything
The delivery method you choose determines the pharmacokinetics. That is not just academic. It is why some patients feel a rollercoaster, why others plateau at low numbers despite clean injections, and why a gel can make or break adherence. Matching the person to a delivery method is one of the most important decisions in hormone therapy.
Intramuscular and subcutaneous injections. Testosterone cypionate and enanthate are workhorses. A single 200 mg shot every two weeks is convenient for clinics, not for patients. It creates a high peak on days one and two, then a steady fall to low troughs near day 14. Most men feel great, then flat. Weekly dosing reduces that swing. Splitting to twice weekly, or even every three days, smooths peaks further. I often start with subcutaneous injections using a small needle in the thigh or abdomen, which many patients find easier and less painful than intramuscular gluteal shots. Absorption is sound, and the day to day feel is steadier. Consistency matters more than the exact site.
Transdermal gels and solutions. Commercial gels, 1 to 2 percent, applied daily, offer steady levels when used correctly. Correctly is doing the same routine each morning after the shower, applying to clean, dry skin with time to absorb before dressing, and avoiding immediate contact that could transfer medication. Steady state arrives in several days, changes in dose show up within a week, and levels can be fine tuned in small steps. The main drawbacks are variable absorption, lower peak levels in some men, and the nuisance of daily application. For some, those are assets, not problems. In men with high hematocrit on injections, gels can lower the risk.
Oral testosterone undecanoate. The modern oral TU is absorbed via the lymphatics when taken with dietary fat. It avoids first pass liver metabolism, which makes it safer than older oral formulations, but timing with meals is not optional. Miss the fat, miss the absorption. Peaks occur a few hours after dosing, so the lab draw must match that timing if you want numbers that make sense. I use it in men who will not inject and dislike gels, and in some who get erythrocytosis on parenteral therapy. Twice daily dosing is common. Consistency with meals is non negotiable.
Nasal gel. The intranasal option, applied three times daily, produces small peaks and minimal transfer risk. It suits a subset who want a quick on and quick off profile, or those who need to avoid higher cumulative exposure. Adherence can be the limiting factor.
Pellet implants. Hormone pellet therapy provides months of exposure from a minor in office procedure. It eliminates adherence worries and peaks and troughs are modest after the initial weeks. The trade off is inflexibility. If libido is too high or acne flares, you wait it out. Dosing is algorithmic and depends on body mass and prior response. I reserve pellets for those who have stabilized on injections or gels and want convenience with known response. For women receiving very low dose testosterone for sexual function as part of broader BHRT, pellets can be effective when carefully sized and spaced, though I prefer the flexibility of transdermal or sublingual routes during titration.
Compounded creams versus FDA approved products. Compounded bioidentical hormones allow micro dosing and combination with estradiol or progesterone in integrative hormone therapy plans. Quality depends on the pharmacy. I work with pharmacies that validate potency and use vehicles with reliable absorption, then I confirm with clinical response and labs. When legal coverage or predictability is key, FDA approved options are my default, especially for men.
Injections versus gels is the most common decision. If a patient travels and hates needles, gel wins. If a patient needs fertility preserved, injections plus adjuncts are easier to manage. If hematocrit creeps, gel or oral TU may be safer. Each route has a story, not just a label.
What to test, and when to test it
You cannot optimize what you do not measure, and you cannot interpret testosterone without context. Timing the draw relative to the last dose is as important as what you order. I have watched many smart clinicians make a change based on a mistimed lab, only to backtrack weeks later.
Here is the lab framework that keeps treatment safe and effective:
- Baseline: total testosterone, SHBG, albumin, free testosterone by equilibrium dialysis if available or calculated with a validated equation, CBC with hematocrit, comprehensive metabolic panel, lipid panel, A1c if metabolic risk, TSH, prolactin if total testosterone is very low or libido issues are disproportional, estradiol by sensitive LC/MS assay in men, PSA in men over 40 to 50 or with prostate history. In women, use assays and ranges appropriate for female physiology. Timing: for weekly injections, draw a trough the morning before the next dose. For twice weekly injections, draw midway between doses. For gels, draw at a consistent time, usually 2 to 6 hours after application, and use that timing every time. For oral TU, draw 3 to 5 hours after the morning dose with fat. For pellets, check near mid cycle once levels stabilize. Early follow up: recheck CBC, total and free testosterone, estradiol, and chemistry at 6 to 8 weeks after starting or adjusting dose. Adjust in small steps. Reassess symptoms. Ongoing: every 3 to 6 months in the first year, then every 6 to 12 months if stable. Include PSA in men as age appropriate, and consider sleep apnea screening if snoring or daytime sleepiness appears. Monitor blood pressure, waist circumference, and body composition where feasible. Safety thresholds: hematocrit at or above 54 percent calls for a pause, dose reduction, route change, or therapeutic phlebotomy if clinically indicated. Rising PSA or an abnormal exam warrants urology input. Significant edema, dyspnea, or polycythemia symptoms need immediate attention.
Reading labs with judgment
Interpreting testosterone is part math, part pattern recognition. A total testosterone of 650 ng/dL with SHBG of 65 nmol/L produces a very different free fraction than the same total with SHBG at 15. A man with metabolic syndrome and low SHBG often does best with smaller, more frequent injections to reduce peaks and keep free testosterone steady. Conversely, a lean endurance athlete with high SHBG may need a slightly higher total level to achieve a normal free concentration and feel human again.
Estradiol in men is the most misunderstood lab in hormone clinics. Much of the anxiety comes from poor assays and misattributed symptoms. Use a sensitive estradiol assay. Expect estradiol to rise with testosterone. That is not a pathology by itself. I rarely start aromatase inhibitors up front. When I do use them, it is for a short interval in men with clear estrogen excess symptoms such as breast tenderness or refractory water retention, and I use the smallest dose possible while focusing on correcting the testosterone peaks that usually drive the issue. Long term anastrozole in a man on TRT often leads to joint aches, mood flattening, and unfavorable lipids.
Hematocrit climbs with dose, peaks, and sleep apnea. If a patient on 200 mg every two weeks has a hematocrit of 53 percent and feels like his heart is pounding at night, splitting the dose to 80 to 100 mg weekly or 40 to 60 mg hormone therapy twice weekly plus sleep evaluation often solves it without phlebotomy. Gels and oral TU usually raise hematocrit less than injections, another reason to consider route change if the trend persists.
PSA requires context. Testosterone therapy does not appear to cause prostate cancer. It can unmask pre existing disease as prostate tissue responds to androgens. Baseline PSA helps interpret changes. A modest rise after starting therapy can be physiologic. A sharp jump or total above age adjusted norms deserves evaluation.
Practical dosing patterns that work
Every clinic develops its own favorite on ramps. What matters is that the patient is heard and the labs are timed well. Here are patterns I return to because they drive stable levels and fewer side effects.
Injections done small and steady. For men who like injections, start between 50 and 80 mg of testosterone cypionate twice weekly, reassess at 6 to 8 weeks, and adjust by 10 to 20 mg per week as needed. This schedule blunts peaks, and most men report smoother energy, fewer mood swings, and less acne.
Gels as the long game. For men with needle aversion, cardiovascular risk, or rising hematocrit, daily transdermal therapy with 50 to 100 mg applied to shoulders or upper arms produces a quiet physiology. Educate about skin prep and transfer precautions. Recheck levels at one week, then at six weeks after dose changes.
Oral TU with breakfast and dinner, consistently. If meals are irregular, this route fails. When paired with a routine, it is steady and well tolerated. Expect numbers to be sensitive to diet composition.
Pellets for the person who is already dialed in. Pellets shine when life is busy and the person knows how they respond. Avoid starting here. Use pellets only after you have confirmed a stable sweet spot with another route.
Women and micro dosing. In women, I prefer compounded transdermal formulations at very low doses, reassessed frequently, and always paired with a conversation about priorities like sexual function, mood, and energy. Labs support the story but do not drive it.
The role of hCG, SERMs, and fertility
Testosterone therapy will suppress the hypothalamic pituitary gonadal axis. That is fine if fertility is not a goal, but it is a problem if a man wants to conceive in the next 6 to 12 months. There are two viable paths. Use human chorionic gonadotropin with TRT to maintain intratesticular testosterone and support spermatogenesis, or use selective estrogen receptor modulators like clomiphene to stimulate endogenous testosterone production without exogenous testosterone. Both have trade offs. Clomiphene can improve total and free testosterone to midrange in many younger men with functional secondary hypogonadism. It often preserves fertility, but some men feel edgy or flat on it, and libido responses vary. hCG can maintain testicular volume and fertility signals alongside TRT, but it adds injections, cost, and sometimes more estrogenic side effects due to elevated intratesticular testosterone. I discuss timelines, goals, and tolerance for complexity before deciding.
" width="560" height="315" style="border: none;" allowfullscreen="" >
Managing edge cases and curveballs
High SHBG with normal total testosterone. This shows up in lean men, endurance athletes, and some with hyperthyroidism or liver conditions. Free testosterone is the key marker. I adjust dose to normalize free T, not total, while searching for the upstream driver of high SHBG.
Low SHBG with modest total testosterone but very high free fraction. Common in insulin resistance and obesity. These patients often feel wired on large injections and do better with micro dosing, lifestyle work, and weight reduction strategies. It is not unusual to see dramatic improvements in free testosterone after a 5 to 10 percent weight loss and improved sleep.
Acne that derails therapy. Reduce peaks by splitting the dose and consider a small step down in total weekly milligrams. Topical retinoids and structured skincare help. Persistent, cystic acne may respond to dermatology support without sacrificing hormone therapy.
Mood swings after injections. Check timing. If irritability shows up 24 to 48 hours after a large dose, reduce the per injection amount and increase frequency. If irritability is baseline and predates therapy, treat the mood disorder directly and use a delivery method with the smoothest profile.
Gynecomastia worries. True glandular gynecomastia is slow to form and slow to resolve. Breast tenderness within weeks of starting TRT is usually an estrogen fluctuation. Dose smoothing works better than hammering aromatase.
Lifestyle, sleep, and the rest of the orchestra
Testosterone is part of a broader endocrine symphony. If sleep is broken, cortisol is chronically elevated, or thyroid function is marginal, testosterone therapy does half the job. Resistance training three to four days per week amplifies results. Adequate protein, real fiber, and moderated alcohol reduce aromatase activity and visceral fat. Treat sleep apnea outright. Modest changes alter lab needs. I have watched hematocrit stabilize and free testosterone increase with nothing more than better sleep, lower body fat, and smaller, more frequent doses.
A quick patient story that crystallizes the process
A 48 year old man came in after nine months of testosterone cypionate at 200 mg every two weeks administered at a local clinic. Day two he felt superhuman. By day nine he felt dull, with headaches and restless sleep. Hematocrit was 53.7 percent, PSA stable at 0.9 ng/mL, estradiol on a nonsensitive assay read as 12 pg/mL, which did not fit his breast tenderness. We changed to 60 mg subcutaneous every three and a half days, switched to a sensitive estradiol assay, and repeated labs as a trough two months later. Total testosterone averaged 720 ng/dL, free testosterone sat in the mid range for his lab, estradiol was 28 pg/mL, hematocrit fell to 49.8 percent, and the headaches vanished. He kept his training the same and lost two inches off his waistline over the next quarter. The only variable we touched was the delivery schedule and the lab timing.
What good follow up feels like
Follow up should feel like a collaborative audit. We review sleep, energy, mood, libido, training, and recovery. We cross check with labs collected at the right times. We move the dose dial in small clicks. If a patient or clinician feels the need to change two or three variables at once, I slow it down. One change at a time reveals the signal in the noise.
A simple check-before-you-adjust list
- Was the lab timed correctly for the delivery route and dosing schedule Is SHBG skewing your interpretation of total testosterone Are symptoms pointing to peaks and troughs that dose splitting could smooth Is estradiol measured with a sensitive assay before considering an aromatase inhibitor Has sleep, alcohol, or training volume changed since the last visit
Safety, contraindications, and responsible use
Hormone therapy is powerful medicine. Men with active prostate cancer or breast cancer are not candidates for TRT. Uncontrolled severe sleep apnea, untreated polycythemia, and advanced heart failure require caution and co management. A strong family history of thrombosis necessitates a thoughtful risk discussion and may alter your choice of route and dose. Monitor blood pressure and lipids, particularly if a patient shifts from a sedentary lifestyle to high intensity training on therapy. Watch for edema in those with kidney or heart disease. Keep communication open with the primary care physician and specialists. Good hormone clinics do not operate in isolation.
For women, the boundary lines are equally important. Voice changes and clitoral enlargement can be permanent. Dosing must be cautious and individualized, with clear goals such as improving sexual desire or specific mood and energy targets. I routinely pair low dose testosterone with estrogen and progesterone therapy in menopause when appropriate, always at female physiologic levels, and always with informed consent about benefits and risks.
Transgender care demands clarity and compassion. Goals should be explicit, from desired physical changes to fertility planning. Baseline and ongoing labs mirror those used in TRT but with attention to the pace of change and the additional needs of gender affirming care such as gynecologic health for those with a uterus and cervix, or bone density in the long term.
Putting it together, the art and the science
Hormone optimization is both engineering and craftsmanship. The engineering comes from kinetics, assays, and reference ranges. The craftsmanship shows up in how you connect those facts to a person’s life. Pick the delivery route that fits the person. Use labs to reinforce what symptoms are already telling you. Make small changes, then wait long enough to see their true effect. Respect safety thresholds. Avoid the temptation to fix every bump with another prescription when a timing change will solve it.
The most gratifying part of this work is watching stability settle in. A man who no longer rearranges his week around an injection day, a woman who rediscovers desire without trading it for acne or agitation, a trans man who sees changes arrive at a manageable pace while feeling steady at work. Those results come from careful dosing, thoughtful delivery, and honest labs. That is hormone optimization, not as a slogan, but as a method.